Productronica 2025 brings together leading companies from the global electronics manufacturing industry. Messe.TV provides in ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, ...

Automation Alley, Michigan's Digital Transformation Insight Center, today announced its 2026 Integr8 Series featuring six ...

The U.S. manufacturing industry–the world’s second largest and a global leader in advanced manufacturing–continues to grow ...

The Global Smart Manufacturing Market is projected to grow from USD 230.2 Billion in 2024 to USD 1,097.26 Billion by 2035, registering a strong CAGR of 15.25% from 2025 to 2035. This rapid expansion ...

Cellares to provide proof-of-concept manufacturing for a key BMS CAR-T cell therapy Cellares' proprietary Cell Shuttle is a cost-efficient, reliable, fully automated, and highly scalable manufacturing ...

Many of us have seen photos of and read stories about robots working on the production floor in factories, speeding up old-school assembly lines to build products more quickly. And while the robotics ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, ...

Rockwell Automation’s Bob Buttermore shared the timeline of transformative technology implementations in the company’s own ...

Lyell Immunopharma will evaluate Cellares’ automated manufacturing platform, the Cell Shuttle™, through Cellares’ Technology Adoption Partnership (TAP) program. As part of the collaboration, the ...

Participants explore the various vendor booths at the Manufacturers Resource Center’s Automation & Manufacturing Technology Show Thursday, April, 25, 2024, at the Delta Hotel by Marriott, in Macungie.

Collaboration with intent to validate Cellares’ Cell Shuttle platform for manufacturing of CABA-201, Cabaletta Bio’s fully human CD19-CAR T product candidate, which is being evaluated in parallel ...